Keppra-XR Dosage
Generic name: LEVETIRACETAM 500mg
Dosage form: tablet, film coated, extended release
Drug class: Pyrrolidine anticonvulsants
Medically reviewed by Drugs.com. Last updated on Apr 22, 2024.
Recommended Dosing
For adults and adolescent patients, the recommended dosing for monotherapy and adjunctive therapy is the same; as outlined below.
Dosage Adjustments in Adult Patients with Renal Impairment
KEPPRA XR dosing must be individualized according to the patient's renal function status. Recommended dosage adjustments for adults are shown in Table 1. In order to calculate the dose recommended for patients with renal impairment, creatinine clearance adjusted for body surface area must be calculated. To do this, an estimate of the patient's creatinine clearance (CLcr) in mL/min must first be calculated using the following formula:
CLcr= | [140-age (years)] × weight (kg) -------------------------------------- |
(× 0.85 for female patients) |
72 × serum creatinine (mg/dL) |
Then CLcr is adjusted for body surface area (BSA) as follows:
CLcr (mL/min/1.73m2)= | CLcr (mL/min) ------------------------- |
× 1.73 |
BSA subject (m2) |
Group | Creatinine Clearance (mL/min/1.73m2) |
Dosage (mg) |
Frequency |
---|---|---|---|
Normal | > 80 | 1000 to 3000 | Every 24 hours |
Mild | 50 – 80 | 1000 to 2000 | Every 24 hours |
Moderate | 30 – 50 | 500 to 1500 | Every 24 hours |
Severe | < 30 | 500 to 1000 | Every 24 hours |
More about Keppra XR (levetiracetam)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Drug images
- Latest FDA alerts (5)
- Side effects
- During pregnancy
- Generic availability
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Elepsia XR, Spritam, Roweepra, Roweepra XR
Professional resources
Other brands
Elepsia XR, Spritam, Roweepra, Roweepra XR
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.